3 Upcoming Biotech Catalysts To Watch
“If you only have enough time to keep up with a handful of biotech catalysts that are on the way soon, these three are well worth your attention.”
Stocks
Do These 2 Disruptive Small-Cap Biotech Stocks Have The Potential To Be Millionaire Makers?
Regarding the two stocks he highlights, the author of today’s article declares “these two small-caps are both first movers in healthcare sectors that are ripe for disruption, with massive opportunities over the next decade.”
This Oncology Company’s “Platform In A Pill” Cancer Treatment Could Be A Massive Opportunity
RAS mutations are the initiating genetic events in many cancers – and have proven to be extremely difficult to target. With its lead compound, however, the oncology company featured in today’s article is “looking to become the backbone of treatment for RAS-driven cancers.
4 Stocks To Watch On Proposed Health Care Infrastructure Spending
When you think of infrastructure, you likely think of things such as roads, bridges and airports. But the infrastructure plan the Biden Administration just rolled out also includes hundreds of billions of dollars in funding for health care infrastructure.
New Stocks To Watch In Biotech, Tech, Cannabis & More
A clinical-stage company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases is among the three new biotech stocks to watch.
2 Biotech/Pharma Penny Stocks With “Strong Buy” Ratings – And Massive Upside Potential
Two penny stocks that boast “Strong Buy” consensus ratings from the analyst community and massive upside potential.
What’s Buyable In Biotech After Recent Pullback?
The recent pullback in biotech “offers a chance to get into exciting areas of biotech research like gene editing and oncology at better prices.”
2 Clinical-Stage Biotechs With Upside Potential Over 100%
Two clinical-stage biotech stocks with the potential to deliver gains of 100% or more.
Why This Could Be The Best Coronavirus Stock “Even In A World Without COVID-19”
What makes the genetic testing and sequencing company featured in today’s article potentially the best coronavirus stock investors can buy right now?
“The Most Growth, At The Cheapest Price”
What are the most affordable biopharmaceutical growth stocks in the S&P 500 right now? Or, as today’s article puts it, which biopharma stocks in the… Read More »“The Most Growth, At The Cheapest Price”